Bacteria have developed mechanisms to communicate and compete with one another in diverse environments 1 . A new form of intercellular communication, contact-dependent growth inhibition (CDI), was discovered recently in Escherichia coli 2 . CDI is mediated by the CdiB/CdiA two-partner secretion (TPS) system. CdiB facilitates secretion of the CdiA 'exoprotein' onto the cell surface. An additional small immunity protein (CdiI) protects CDI 1 cells from autoinhibition 2,3 . The mechanisms by which CDI blocks cell growth and by which CdiI counteracts this growth arrest are unknown. Moreover, the existence of CDI activity in other bacteria has not been explored. Here we show that the CDI growth inhibitory activity resides within the carboxy-terminal region of CdiA (CdiA-CT), and that CdiI binds and inactivates cognate CdiA-CT, but not heterologous CdiA-CT. Bioinformatic and experimental analyses show that multiple bacterial species encode functional CDI systems with high sequence variability in the CdiA-CT and CdiI coding regions. CdiA-CT heterogeneity implies that a range of toxic activities are used during CDI. Indeed, CdiA-CTs from uropathogenic E. coli and the plant pathogen Dickeya dadantii have different nuclease activities, each providing a distinct mechanism of growth inhibition. Finally, we show that bacteria lacking the CdiA-CT and CdiI coding regions are unable to compete with isogenic wild-type CDI 1 cells both in laboratory media and on a eukaryotic host. Taken together, these results suggest that CDI systems constitute an intricate immunity network with an important function in bacterial competition.
Bacteria have developed mechanisms to communicate and compete with one another in diverse environments 1 . A new form of intercellular communication, contact-dependent growth inhibition (CDI), was discovered recently in Escherichia coli 2 . CDI is mediated by the CdiB/CdiA two-partner secretion (TPS) system. CdiB facilitates secretion of the CdiA 'exoprotein' onto the cell surface. An additional small immunity protein (CdiI) protects CDI 1 cells from autoinhibition 2, 3 . The mechanisms by which CDI blocks cell growth and by which CdiI counteracts this growth arrest are unknown. Moreover, the existence of CDI activity in other bacteria has not been explored. Here we show that the CDI growth inhibitory activity resides within the carboxy-terminal region of CdiA (CdiA-CT), and that CdiI binds and inactivates cognate CdiA-CT, but not heterologous CdiA-CT. Bioinformatic and experimental analyses show that multiple bacterial species encode functional CDI systems with high sequence variability in the CdiA-CT and CdiI coding regions. CdiA-CT heterogeneity implies that a range of toxic activities are used during CDI. Indeed, CdiA-CTs from uropathogenic E. coli and the plant pathogen Dickeya dadantii have different nuclease activities, each providing a distinct mechanism of growth inhibition. Finally, we show that bacteria lacking the CdiA-CT and CdiI coding regions are unable to compete with isogenic wild-type CDI 1 cells both in laboratory media and on a eukaryotic host. Taken together, these results suggest that CDI systems constitute an intricate immunity network with an important function in bacterial competition.
CDI was discovered in E. coli strain EC93, which inhibits the growth of other E. coli strains on direct cell-to-cell contact 2 . Epitope insertion mutagenesis revealed the importance of the CdiA-CT in CDI 2 . Genetic and antibody blocking experiments identified BamA, an essential protein required for outer membrane biogenesis, as the CDI receptor on target cells 3 . The inner membrane multidrug transporter AcrB may also have a function, because acrB mutants, like bamA mutants, are resistant to CDI 3 . For EC93-mediated CDI, growth inhibition coincides with dissipation of the proton motive force across the cytoplasmic membrane, decreased aerobic respiration and decreased ATP levels in the target cells 4 . EC93 is protected from autoinhibition by CdiI, which is encoded immediately downstream of cdiA (ref. 2). These data suggest that CdiA binds BamA and delivers a signal, possibly a CdiA-derived toxin, which then inhibits target cell growth. CdiI could confer immunity on cells by binding to the CdiA peptide or otherwise neutralizing the growth inhibitory signal ( Supplementary Fig. 1a ).
Previous complementation analysis indicated the presence of functional cdiB and cdiA homologues in uropathogenic E. coli (UPEC), but no cdiI homologue was identified 2, 5 . Inspection of the cdi locus from E. coli UPEC 536 revealed a small open reading frame in the same relative location as, but lacking significant sequence identity to, cdiI EC93 . Expression of this open reading frame (cdiI 536 ) protected E. coli from growth inhibition mediated by cells expressing CdiA 536 , but not from cells expressing CdiA EC93 (Fig. 1a) . Similarly, CdiI EC93 only provided immunity to cells expressing CdiA EC93 (Fig. 1a ). The protection conferred by CdiI therefore seems to be limited to its cognate CDI system. Alignment of CdiA EC93 and CdiA 536 showed that about 3,000 residues at the amino terminus (up to and including a common VENN peptide motif) are 78% identical, but about 220 residues at the C terminus share no significant similarity 6 ( Fig. 1b ).
To determine whether the dissimilar C termini of CdiA EC93 and CdiA 536 account for the specificity of CdiI-mediated immunity, we replaced the coding sequences for CdiA-CT 536 and CdiI 536 in UPEC 536 with the corresponding region from EC93. The resulting strain produced a chimaeric CdiA protein in which the C-terminal 223 residues of CdiA EC93 were fused to the N-terminal 3,020 residues of CdiA 536 . UPEC 536 producing this chimaeric CdiA inhibited target cells expressing CdiI 536 but not cells expressing CdiI EC93 , whereas the converse was true for wild-type UPEC 536 ( Fig. 1c ). These results show that CdiA-CT EC93 is functional when grafted to the CdiA molecule from UPEC 536, and that the CdiA-CT sequence is important for specificity of immunity.
The observation that CdiI-mediated immunity is specific to the CdiA-CT suggests that growth inhibitory activity is also contained within the CdiA-CT. Expression of the C-terminal 268 residues of CdiA EC93 inside E. coli cells inhibited growth, and this inhibition was blocked by the co-production of CdiI EC93 but not by that of CdiI 536 ( Fig. 2a ). Because the CdiA-CT lacks a secretion signal sequence, it is likely that this CdiA-CT-mediated growth inhibition and CdiImediated immunity occur within the cytoplasm. The minimal active region of CdiA-CT EC93 was determined by deletion analysis. Removal of up to 25 residues from the N terminus of the 268-residue CdiA-CT EC93 construct did not significantly affect growth inhibitory activity ( Fig. 2b ). Removal of 45 residues from the N terminus, which includes the conserved VENN motif, yielded a polypeptide with about tenfold greater inhibitory activity. Deletion of an additional 13 residues from the N terminus completely abrogated activity ( Fig. 2b ). Deletion of as few as 12 residues from the C terminus of the CdiA-CT EC93 construct also abolished inhibitory activity. Thus, the growth inhibitory activity resides within the C-terminal 223 amino-acid residues of CdiA EC93 .
We next searched for additional cdiBAI loci in other E. coli strains. Although several cdiBAI gene clusters are present in partly assembled E. coli genome sequences ( Supplementary Table 1 ), we limited our analysis to the 33 fully assembled E. coli genomes currently available. Two E. coli isolates, UTI89 and CFT073, encode two-partner secretion systems related to EC93 CdiB/CdiA. The UTI89 CDI module is identical to that of UPEC 536 and is located within the same pathogenicity island (PAI II 536 ) in both strains ( Supplementary Fig. 2a ) 7 . In contrast, the CFT073 CDI locus resides in an unrelated pathogenicity island (PAI-CFT073-aspV) 5 , and its predicted CdiA-CT and CdiI sequences show no similarity to the UPEC 536 or EC93 systems (Supplementary Figs 2b, c and 3b). The CdiA-CT of EC93 is unrelated to the CdiA-CTs identified in other fully sequenced E. coli strains; however, it is 42% identical to the CdiA-CT from another species, Edwardsiella tarda EIB202. This, together with the sporadic occurrence of cdi loci in E. coli strains and their association with genomic islands, suggests that these genes may be transferred horizontally.
Bioinformatic analyses showed that CDI systems are widespread among other Gram-negative bacteria, with representatives identified in a variety of a-proteobacteria, b-proteobacteria and c-proteobacteria (Supplementary Table 1 and Supplementary Fig. 3 ). Although widely distributed, only certain strains of any given species contain cdiBAI homologues. Some bacterial isolates encode multiple CDI modules; for example, Bartonella grahamii strain as4aup and Photorhabdus luminescens subsp. laumondii contain four and five CDI modules, respectively ( Supplementary Fig. 3b ). On the basis of their similarity to CdiA EC93 , each putative cdiA homologue is likely to encode a TpsA family member with an N-terminal haemagglutination activity domain (Pfam PF05860, also called a TPS domain) and haemagglutinin repeats that are predicted to form a b-helical structure. In addition, most cdiA homologues encode the VENN peptide motif, which is part of the DUF638 domain of unknown function (Pfam PF04829) ( Fig. 1b and Supplementary Fig. 3a ). In general, significant variability between CdiA-CT/CdiI protein sequences was observed between different species and between different CdiA-CTs encoded within a single strain. There are instances in which an extended genomic region, including the CDI module, is conserved between different strains of the same species (as in E. coli UPEC 536 and UTI89, and most Yersinia pestis strains); in such cases the entire CdiA protein and CdiI are highly conserved. Burkholderia species also seem to encode CdiB/ CdiA two-partner secretion systems, but these loci have a different gene organization (cdiAIB rather than cdiBAI) and the putative CdiA proteins lack the DUF638 domain. Instead of the VENN motif, the Burkholderia cdiA homologues encode an NxxLYN motif that precedes variable C-terminal domains ( Supplementary Fig. 3c ). In all instances, the Burkholderia cdiA genes are followed by short open reading frames, which may be analogous to the cdiI genes in E. coli.
To determine whether the in silico-identified cdi loci encode functional CDI systems, we replaced the CdiA-CT and CdiI coding regions of UPEC 536 with the corresponding sequences from Y. pestis CO92 and the region 2 CDI module from D. dadantii 3937 (Supplementary Table 1 ). UPEC 536 producing chimaeric CdiAs inhibited target cells expressing heterologous CdiI proteins but not cells expressing cognate CdiI (Fig. 1c) , strongly suggesting that Y. pestis CO92 and D. dadantii 3937 encode CDI systems with allele-specific immunity proteins. These data also indicate that the N-terminal 3,020 residues of CdiA 536 are capable of delivering functional CdiA-CT domains from Y. pestis CO92 and D. dadantii 3937 into target cells. CdiA-CT construct was tested for growth inhibitory activity when expressed in E. coli cells (11, growth was blocked immediately after CdiA-CT EC93 induction; 1, growth was blocked after a delay of 2-3 h; 2, no growth inhibition).
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How do CdiI immunity proteins protect against cognate CdiA-CT? We speculated that CdiI prevents CDI-mediated autoinhibition by binding specifically to the C terminus of cognate CdiA. To test this hypothesis, we examined the interaction between CdiA-CT and hexahistidine-tagged CdiI (CdiI-His 6 ) proteins using Ni 21 -affinity pull-down experiments. Because the CdiA-CTs used in these experiments lack His 6 -epitope tags, their retention on Ni 21 -nitrilotriacetic acid (Ni 21 -NTA) resin is dependent on binding to CdiI-His 6 . CdiA-CT 536 was retained by the Ni 21 -NTA resin when preincubated with CdiI 536 -His 6 but not when preincubated with non-cognate CdiI 3937-2 -His 6 (Fig. 3a) . Reciprocally, CdiA-CT 3937-2 bound to the resin only in the presence of cognate CdiI 3937-2 -His 6 (Fig. 3a) . These data indicate that CdiI proteins bind to CdiA-CT in vitro in an allele-specific manner.
To determine whether CdiA-CT and CdiI bind one another in vivo, we used a modified bacterial two-hybrid system. In this system, proteins of interest are fused to the T18 and T25 domains of adenylate cyclase, and binding of the two fusion proteins results in the production of cyclic AMP, which is monitored indirectly through the expression of a b-galactosidase reporter 8 . Co-expression of cognate T25-CdiA-CT 536 and CdiI 536 -T18 fusions, or T25-CdiA-CT 3937-2 and CdiI 3937-2 -T18 fusions, yielded high activities of b-galactosidase (more than 300 Miller units) in both cases (Fig. 3b ). Because CdiA-CTs are cytotoxic in the absence of cognate CdiI, we used green fluorescent protein (GFP) as a negative control to test binding specificity. Coexpression of T25-GFP and CdiI 536 -T18, or T25-GFP and CdiI 3937-2 -T18, resulted in very low b-galactosidase activities (Fig. 3b ). Taken together, these data demonstrate that CdiI immunity proteins bind to their cognate CdiA-CTs in vitro and in vivo.
How do CDI systems inhibit target cell growth? Most CdiA-CTs are not similar to known proteins or protein domains. However, we found that the C-terminal 132 residues of CdiA 3937-2 from D. dadantii 3937 shares 35% identity with the pyocin S3 nuclease domain from Pseudomonas aeruginosa ( Supplementary Fig. 4 ). Pyocin S3 is cytotoxic by virtue of its DNase activity 9 , suggesting that CdiA 3937-2 may also use nuclease activity to inhibit target cell growth. We confirmed that purified CdiA-CT 3937-2 possesses a robust Mg 21 -dependent DNase activity, capable of completely digesting linear and supercoiled plasmid DNA ( Fig. 3c , and data not shown). We also examined the activity of CdiA-CT 536 , which does not share sequence homology with other known toxins or colicins, and found that it could cleave transfer RNA (Fig. 3d) . Purified CdiA-CT 536 readily cleaved several E. coli tRNA species, but not ribosomal RNA or messenger RNA (Fig. 3d, and data not shown). For each CdiA-CT, the addition of purified cognate CdiI blocked nuclease activity, whereas the addition of heterologous CdiI had no effect on activity (Fig. 3c, d) . These results suggest that CDI systems use more than one mechanism to inhibit cell growth. If these DNase and tRNase activities are responsible for growth inhibition, then the CdiA-CTs must be translocated into the target cell cytoplasm ( Supplementary Fig. 1 ). According to this model, CdiI proteins confer immunity to CDI by binding to cognate CdiA-CTs and blocking their enzymatic activities. Given the diversity of CdiA-CT sequences ( Fig. 1b and Supplementary Fig. 3) , it seems likely that additional growth inhibitory mechanisms will be identified for other CDI systems.
It is not known when or where CDI systems are deployed in the environment, nor what precise biological function or functions they provide. UPEC 536 does not express the cdiBAI gene cluster under standard laboratory growth conditions (S.K.A., J.S.W. and D.A.L., unpublished observations). However, EC93 expresses cdiBAI constitutively 2 . To determine whether the CDI system in EC93 provides a selective advantage, we deleted the CdiA-CT and CdiI coding sequences of EC93 and mixed the resulting mutant cells with wild-type EC93 at a 1:1 ratio in a growth competition experiment. After 3 h of co-culture, EC93DcdiA-CTDcdiI mutant bacteria were less than 1% of wild-type EC93 cells (competitive index less than 10 22 ; Fig. 4a ). However, EC93DcdiA-CTDcdiI cells expressing CdiI EC93 from a plasmid were able to compete equally with wild-type EC93, indicating that the original loss of fitness was due to the mutant's susceptibility to CDI (Fig. 4a) . These results indicate that CDI systems may be significant in intraspecies competition between bacteria occupying the same ecological niche. Further support for this conclusion came from an analysis of D. dadantii. Previous work has shown that disruption of a putative cdiI gene, designated virA, decreases the virulence of D. dadantii EC16 on plant hosts 10 .
Our results indicate that VirA binds and inactivates the C-terminal domain of HecA EC16 , a CdiA homologue (Supplementary Table 1 , and data not shown). These results suggest that D. dadantii may express cdi genes on plants. We used the fully sequenced D. dadantii 3937 strain, which contains two CDI regions (cdi 3937-1 and cdi 3937-2 ; see Supplementary Table 1) , to test the hypothesis that CDI has a function 
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in intrastrain competition. Each of the cdiA-CT/cdiI regions was deleted individually, and the resulting mutants were competed against wild-type D. dadantii 3937 on chicory 11, 12 . Although deletion of the cdi 3937-2 region had no effect on competition, cells lacking cdi 3937-1 were outcompeted by wild-type bacteria, as demonstrated by a competitive index of about 10 21 (Fig. 4b, and data not shown). This competitive disadvantage was reversed by complementation with a chromosomal copy of the cognate cdiI 3937-1 gene (Fig. 4b) . Complementation was specific, because noncognate cdiI EC16 (virA) from D. dadantii EC16 had no effect on the competitive index (Fig. 4b) . These results show that the region 1 CDI system in D. dadantii has a function in growth competition on chicory. The role of the region 2 CDI system is unknown, but it could function under different environmental conditions or target different bacterial species. Taken together, these results strongly indicate that CDI systems function in growth competition in the environment.
METHODS SUMMARY
Strains, plasmids and oligonucleotides used in this study are shown in Supplementary Table 2 . E. coli competition assays were performed as described previously 2 . D. dadantii competition assays on chicory were performed as described in Supplementary Methods. EC93 and D. dadantii 3937 cdiA-CT-cdiI deletions and CdiA chimaeras were constructed with allelic exchange as described previously 13 . For chimaera construction, the 39 end of cdiA and all of cdiI from UPEC 536 Dkps K15 DaraCBA specRExBAD-cdiBAI (DL5646) were replaced with cdiA-CT (sequence immediately following VENNX) and cdiI from E. coli EC93, Y. pestis CO92 (Uniprot accession number Q7CGD9), or D. dadantii 3937 region 2 (see Supplementary Methods) . The Dkps K15 capsule mutation was used to increase the efficacy of CDI, on the basis of our previous results showing that capsule production blocks CDI 3 . Immunity plasmids were constructed by ligating PCR-amplified cdiI genes into plasmid pBR322 under tet promoter control (Fig. 1a, c) . For D. dadantii 3937 the immunity plasmids were constructed by ligating PCR-amplified cdiI genes into the miniTn7 delivery plasmid pUC18R6KT-miniTn7T under tet promoter control (see Supplementary Methods) . Deletion mapping of E. coli EC93 cdiA-CT (Fig. 2b) was performed by cloning specific sequences amplified by PCR into plasmid pLAC11 (ref. 14) under lac promoter control. All plasmids were propagated in EPI100 acrB mutant strain DL5154 to mitigate toxic effects. In vivo interactions between CdiA-CT and CdiI were determined with a modified bacterial two-hybrid system (BACTH; Euromedex) 8 . b-Galactosidase 14 and fluorescence 3 analyses were performed as described previously. In vitro affinity pull-downs with His 6 -tagged CdiI/CdiA-CT were performed with Ni 21 -NTA resin (Qiagen) (Fig. 3a) . CdiA-CT was released by denaturation in buffer containing 6 M guanidinium-HCl, and His 6tagged CdiI was released in native buffer supplemented with 250 mM imidazole. CdiA-CT activities were analysed as described in Supplementary Methods. Complete methods are presented in Supplementary Methods. DcdiA-CT 3937-1 DcdiI 3937-1 alone (cdiI 2 ) or complemented with heterologous cdiI from D. dadantii EC16 (cdiI EC16 ) or cognate cdiI (cdiI 3937-1 ). Cell mixtures were inoculated on chicory leaves (see Supplementary Methods) and incubated for the indicated durations, and viable counts were determined. The competitive index (nal R CFU/gent R CFU) was calculated as described for a at each time point. Results are shown as means and s.d. (n 5 2 experiments). P value at 24 h 5 0.00004. P values were obtained with an unpaired, two-tailed t-test.
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